Stanford’s Department of Neurology is seeking healthy volunteers between the ages of 35 and 85. This study will compare behavior and memory between people with Parkinson’s Disease and healthy people without Parkinson’s Disease. We hope to understand why some people with Parkinson’s disease develop memory problems.
FDA approves new formulation of amantadine for dyskinesia
The FDA has approved amantadine in a new formulation for the dyskinesia in Parkinson’s patients based on a Phase 3 randomized, double-blind, placebo-controlled study reported in JAMA Neurology.
ParkinsonsDisease.net – “Parkinson’s Disease—Going Beyond the Tremor”
The Parkinson’s Disease In America 2017 online survey gathered insights from 1,152 individuals currently suffering from Parkinson’s disease to better understand their symptoms and management of this condition, as well as the impact on their lives. Here are the survey findings…. Full Story>
ScienceDaily: New mechanism behind Parkinson’s disease revealed
Researchers have identified the precise toxic mechanism at work during an overabundance of the protein alpha-synuclein in neurons—the protein is a key causative agent in the development of Parkinson’s disease.
LiveScience: Dreams and Brain Disease: REM Sleep Cells Linked to Disorders
Where do dreams come from? Researchers now say they know: A specific group of cells in the brain stem is responsible for controlling dreaming sleep, also called Rapid Eye Movement (REM) sleep, a new study says…. Full Story>